Entecavir
DrugBank ID: DB00442
Summary
| Metric | Value |
|---|---|
| Total Predictions | 50 |
| KG+DL (Dual Validated) | 1 |
| DL Only | 49 |
| KG Only | 0 |
Predictions
| Indication | Score | Source |
|---|---|---|
| chronic hepatitis C virus infection | 0.9998 | DL |
| hepatitis B virus infection | 0.9985 | DL |
| HIV infectious disease | 0.9980 | DL |
| hepatitis C virus infection | 0.9969 | DL |
| chronic hepatitis B virus infection | 0.9967 | KG+DL |
| feline acquired immunodeficiency syndrome | 0.9965 | DL |
| simian immunodeficiency virus infection | 0.9965 | DL |
| neurodevelopmental disorder with ataxic gait, absent speech, and decreased cortical white matter | 0.9964 | DL |
| hepatitis, viral, animal | 0.9946 | DL |
| hepatitis E virus infection | 0.9945 | DL |
| hepatitis A virus infection | 0.9944 | DL |
| Omsk hemorrhagic fever | 0.9941 | DL |
| Kyasanur forest disease | 0.9939 | DL |
| early-onset familial noncirrhotic portal hypertension | 0.9794 | DL |
| hepatoportal sclerosis | 0.9794 | DL |
| hepatopulmonary syndrome | 0.9794 | DL |
| idiopathic copper-associated cirrhosis | 0.9794 | DL |
| primitive portal vein thrombosis | 0.9794 | DL |
| obsolete familial combined hyperlipidemia | 0.9764 | DL |
| hepatic porphyria | 0.9739 | DL |
| disorder of tyrosine metabolism | 0.9710 | DL |
| disorder of phenylalanine metabolism | 0.9668 | DL |
| teratogenic Pierre Robin syndrome | 0.9642 | DL |
| tetrahydrobiopterin-responsive hyperphenylalaninemia/phenylketonuria | 0.9634 | DL |
| AIDS | 0.9274 | DL |
| fibroma of prostate | 0.9253 | DL |
| benign reproductive system neoplasm | 0.9180 | DL |
| Brenner tumor | 0.9158 | DL |
| benign prostate phyllodes tumor | 0.9136 | DL |
| hepatitis D virus infection | 0.9103 | DL |
| neonatal epileptic encephalopathy due to glutaminase deficiency | 0.8967 | DL |
| male reproductive organ cancer | 0.8960 | DL |
| idiopathic bilateral vestibulopathy | 0.8943 | DL |
| semicircular canal dehiscence syndrome | 0.8943 | DL |
| inborn disorder of phenylalanin or tyrosine metabolism | 0.8919 | DL |
| AIDS related complex | 0.8866 | DL |
| congenital human immunodeficiency virus | 0.8866 | DL |
| genetic otorhinolaryngological malformation | 0.8849 | DL |
| prostate leiomyoma | 0.8795 | DL |
| tetrahydrobiopterin metabolic process disease | 0.8777 | DL |
| juvenile nasopharyngeal angiofibroma (disease) | 0.8776 | DL |
| silent sinus syndrome | 0.8766 | DL |
| familial nasal acilia | 0.8764 | DL |
| prostate cancer/brain cancer susceptibility | 0.8753 | DL |
| propylthiouracil embryofetopathy | 0.8626 | DL |
| maternal hyperthermia induced birth defects | 0.8571 | DL |
| Plasmodium falciparum malaria | 0.8559 | DL |
| cleft lip/palate-intestinal malrotation-cardiopathy syndrome | 0.8558 | DL |
| fetal minoxidil syndrome | 0.8546 | DL |
| branchial cleft anomaly | 0.8530 | DL |
External Links
Disclaimer
Predictions are for research purposes only and do not constitute medical advice.
Predictions are for research purposes only and do not constitute medical advice.